Arlene B. Chapman
- Cardiology and Cardiovascular Medicine top 2%
- Molecular Biology top 10%
- Endocrinology, Diabetes and Metabolism top 2%
- Genetics top 5%
- Pharmacology top 1%
- Co-authors
- Stephen T. TurnerEric BoerwinkleGary L. SchwartzJohn G. GumsJulie A. JohnsonRhonda M. Cooper‐DeHoffYan GongRobert W. Schrier
- Topics
- Hormonal Regulation and Hypertension (24 papers)Pharmacogenetics and Drug Metabolism (16 papers)Blood Pressure and Hypertension Studies (12 papers)
- Partner nations
- United StatesNetherlandsFrance
In The Last Decade
Arlene B. Chapman
87 papers receiving 2.5k citations
Peers
Comparison fields: 5 of 122
- Cardiology and Cardiovascular Medicine 788
- Molecular Biology 757
- Endocrinology, Diabetes and Metabolism 683
- Genetics 382
- Pharmacology 352
Countries citing papers authored by Arlene B. Chapman
This map shows the geographic impact of Arlene B. Chapman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arlene B. Chapman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arlene B. Chapman more than expected).
Fields of papers citing papers by Arlene B. Chapman
This network shows the impact of papers produced by Arlene B. Chapman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arlene B. Chapman. The network helps show where Arlene B. Chapman may publish in the future.
Co-authorship network of co-authors of Arlene B. Chapman
This figure shows the co-authorship network connecting the top 25 collaborators of Arlene B. Chapman. A scholar is included among the top collaborators of Arlene B. Chapman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arlene B. Chapman. Arlene B. Chapman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 2 | |
| 3 | 1 | |
| 4 | 4 | |
| 5 | 21 | |
| 6 | 6 | |
| 7 | 13 | |
| 8 | 8 | |
| 9 | 49 | |
| 10 | 9 | |
| 11 | 6 | |
| 12 | 9 | |
| 13 | 72 | |
| 14 | 11 | |
| 15 | 58 | |
| 16 | 83 | |
| 17 | 56 | |
| 18 | 24 | |
| 19 | [100 cases of generalised postoperative peritonitis (author's transl)]. | 8 |
| 20 | Effets du furosémide chez les malades en insuffisance rénale aiguë. Diminution du recours aux méthodes de dialyse. | 1 |
About Arlene B. Chapman
Arlene B. Chapman is a scholar working on Nephrology, Pharmacology and Endocrinology, Diabetes and Metabolism, having authored 89 papers that have together received 2.6k indexed citations. Recurring topics across this work include Hormonal Regulation and Hypertension (24 papers), Pharmacogenetics and Drug Metabolism (16 papers) and Blood Pressure and Hypertension Studies (12 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (683 citations), Pharmacology (352 citations) and Nephrology (269 citations). Arlene B. Chapman has collaborated with scholars based in United States, Netherlands and France. Frequent co-authors include Stephen T. Turner, Eric Boerwinkle, Gary L. Schwartz, John G. Gums, Julie A. Johnson, Rhonda M. Cooper‐DeHoff, Yan Gong, Robert W. Schrier, Amber L. Beitelshees and Lorna G. Moore. Their work appears in journals such as Journal of Biological Chemistry, PLoS ONE and Diabetes Care.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.